{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:39:24Z","timestamp":1776415164389,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ypmed.2019.105786","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T19:41:46Z","timestamp":1564170106000},"page":"105786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Treating perinatal opioid use disorder in rural settings: Challenges and opportunities"],"prefix":"10.1016","volume":"128","author":[{"given":"Tara M.","family":"Higgins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy J.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie C.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2019.105786_bb0005","unstructured":"21 CFR 1306.07 \u2013 Administering or Dispensing of Narcotic Drugs. Government Publishing Office. https:\/\/www.govinfo.gov\/app\/details\/CFR-1998-title21-vol9\/CFR-1998-title21-vol9-sec1306-07\/related. Accessed 4\/24\/2019."},{"key":"10.1016\/j.ypmed.2019.105786_bb0010","first-page":"711","article-title":"Opioid use and opioid use disorder in pregnancy","author":"American College of Obstetricians and Gynecologists","year":"2017","journal-title":"ACOG Committee Opinion Number"},{"issue":"5","key":"10.1016\/j.ypmed.2019.105786_bb0015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1521-0391.2010.00064.x","article-title":"Co-occuring psychiatric symptoms are associated with increased psychological, social and medical impairment in opioid dependent pregnant women","volume":"19","author":"Benningfield","year":"2010","journal-title":"Am. J. Addict."},{"issue":"4","key":"10.1016\/j.ypmed.2019.105786_bb0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact","volume":"11","author":"Brooklyn","year":"2017","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2019.105786_bb0025","unstructured":"Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders. Substance Abuse and Mental Health Services Administration. https:\/\/ncsacw.samhsa.gov\/files\/Collaborative_Approach_508.pdf Accessed 2\/7\/2019."},{"issue":"6","key":"10.1016\/j.ypmed.2019.105786_bb0030","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"J Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D\u2019Onofrio","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ypmed.2019.105786_bb0035","first-page":"e194","article-title":"Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence","volume":"62","author":"Dooley, et al.","year":"2016","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ypmed.2019.105786_bb0040","doi-asserted-by":"crossref","unstructured":"Gawronski KM, Prasad MR, Backes CR, Lehman KJ, Gardner DK, Cordero L. Neonatal outcomes following in utero exposure to buprenorphine\/naloxone or methadone. SAGE Open Med. 2014; 2:2050312114530282. doi: https:\/\/doi.org\/10.1177\/2050312114530282. eCollection 2014.","DOI":"10.1177\/2050312114530282"},{"issue":"1","key":"10.1016\/j.ypmed.2019.105786_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","article-title":"Trends in pregnancy-associated mortality involving opioids in the United States, 2007\u20132016","volume":"220","author":"Gemmill","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3\u20134","key":"10.1016\/j.ypmed.2019.105786_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15504263.2015.1104484","article-title":"A multidisciplinary approach to the treatment of co-occurring opioid use disorder and posttraumatic stress disorder in pregnancy: a case report","volume":"11","author":"Goodman","year":"2015","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.ypmed.2019.105786_bb0055","unstructured":"Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy. World Health Organization. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/107130\/9789241548731_eng.pdf;jsessionid=B43BD68ECF1AAE573874DBB8F338813F?sequence=1. Accessed 2\/6\/2019."},{"issue":"2","key":"10.1016\/j.ypmed.2019.105786_bb0060","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J. Subst. Abus. Treat."},{"issue":"23","key":"10.1016\/j.ypmed.2019.105786_bb0065","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of maternal first-trimester ondansetron use with cardiac malformation and oral clefts in offspring","volume":"320","author":"Huybrechts","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ypmed.2019.105786_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1177\/1073110518782951","article-title":"Improving rural access to opioid treatment programs","volume":"46","author":"Johnson","year":"2018","journal-title":"Journal of Law, Medicine & Ethics"},{"issue":"4","key":"10.1016\/j.ypmed.2019.105786_bb0075","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/AOG.0000000000002864","article-title":"Pregnancy and naltrexone pharmacotherapy","volume":"132","author":"Jones","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"24","key":"10.1016\/j.ypmed.2019.105786_bb0080","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2019.105786_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011774","article-title":"Observational study of the safety of buprenorphine +naloxone in pregnancy in a rural and remote population","volume":"6","author":"Jumah","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.ypmed.2019.105786_bb0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2019.105786_bb0095","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jrh.12329","article-title":"Maternal opioid use disorder and neonatal abstinence syndrome among rural US residents, 2007\u20132014","volume":"25","author":"Kozhimannil","year":"2019","journal-title":"J. Rural. Health"},{"issue":"6","key":"10.1016\/j.ypmed.2019.105786_bb0100","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"issue":"9","key":"10.1016\/j.ypmed.2019.105786_bb0105","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.ypmed.2019.105786_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/ADM.0000000000000092","article-title":"Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study","volume":"9","author":"Meyer","year":"2015","journal-title":"J. Addict. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2019.105786_bb0115","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000002046","article-title":"Committee opinion number 700: methods for estimating the due date","volume":"129","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ypmed.2019.105786_bb0120","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/AOG.0000000000002352","article-title":"Obstetric care consensus no. 6: periviable birth. American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine","volume":"130","year":"2017","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.ypmed.2019.105786_bb0125","first-page":"e462","article-title":"Integrated care for pregnant women on methadone maintenance treatment: Canadian primary care cohort study","volume":"59","author":"Ordean","year":"2013","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ypmed.2019.105786_bb0130","first-page":"1","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorders in Appalachian states","author":"Patrick","year":"2018","journal-title":"Subst. Abus."},{"issue":"4","key":"10.1016\/j.ypmed.2019.105786_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2018.20851","article-title":"Association among county-level economic factors, clinician supply, metropolitan or rural location, and neonatal abstinence syndrome","volume":"321","author":"Patrick","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ypmed.2019.105786_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2019.105786_bb0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","article-title":"Complex calculations: how drug use during pregnancy becomes a barrier to prenatal care","volume":"15","author":"Roberts","year":"2011","journal-title":"Matern. Child Health J."},{"issue":"4","key":"10.1016\/j.ypmed.2019.105786_bb0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2013.4450","article-title":"Access to treatment for opioid dependence in rural America: challenges and future directions","volume":"71","author":"Sigmon","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ypmed.2019.105786_bb0160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health and Justice."},{"key":"10.1016\/j.ypmed.2019.105786_bb0165","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.ypmed.2019.105786_bb0170","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"5","key":"10.1016\/j.ypmed.2019.105786_bb0175","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid detoxification during pregnancy: a systematic review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2019.105786_bb0185","doi-asserted-by":"crossref","unstructured":"Laslo et al. An overview of available drugs for treatment of opioid abuse during pregnancy. Maternal Health, Neonatology, and Perinatology (2017) 3:4 doi:https:\/\/doi.org\/10.1186\/s40748-017-0044-2.","DOI":"10.1186\/s40748-017-0044-2"},{"key":"10.1016\/j.ypmed.2019.105786_bb0190","doi-asserted-by":"crossref","unstructured":"Nguyen, et al. Brief report: treating women with opioid use disorder during pregnancy in Appalachia: initial neonatal outcomes following buprenorphine-naloxone exposure. Am. J. Addict., 27: 92\u201396, 2018. Epub 2018 Feb 23. doi https:\/\/doi.org\/10.1111\/ajad.12687.","DOI":"10.1111\/ajad.12687"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743519302622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743519302622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T17:12:14Z","timestamp":1574442734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743519302622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":36,"alternative-id":["S0091743519302622"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.105786","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating perinatal opioid use disorder in rural settings: Challenges and opportunities","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2019.105786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105786"}}